Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Silvestri

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Continuum (Minneapolis, Minn.)|December 20, 2022
A Symptoms and Signs Approach to the Patient With Neuromuscular WeaknessNicholas J Silvestri
Muscle & Nerve|January 2, 2025
Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single CenterNicholas J Silvestri
Muscle & Nerve|January 7, 2022
Iatrogenic immunodeficiency-associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravisKate Zha, Nicholas J Silvestri
Muscle & Nerve|March 10, 2023
The diagnosis of myasthenia gravis: The sensitive issue of specificityNicholas J Silvestri, Pushpa Narayanaswami
Muscle & Nerve|March 28, 2017
Start high, then go low: An effective strategy in the treatment of myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Journal of Clinical Neuromuscular Disease|May 30, 2014
Treatment-refractory myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Neurologic Clinics|April 16, 2018
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and EpidemiologyMichael K Hehir, Nicholas J Silvestri
Neurology|January 22, 2016
Comment: Salbutamol--A means to an endplateGil I Wolfe, Nicholas J Silvestri
Seminars in Neurology|November 3, 2012
Myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Muscle & Nerve|April 30, 2013
Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia)Nicholas J Silvestri, Gil I Wolfe
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Continuum (Minneapolis, Minn.)|December 20, 2022
A Symptoms and Signs Approach to the Patient With Neuromuscular WeaknessNicholas J Silvestri
Muscle & Nerve|January 2, 2025
Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single CenterNicholas J Silvestri
Muscle & Nerve|January 7, 2022
Iatrogenic immunodeficiency-associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravisKate Zha, Nicholas J Silvestri
Muscle & Nerve|March 10, 2023
The diagnosis of myasthenia gravis: The sensitive issue of specificityNicholas J Silvestri, Pushpa Narayanaswami
Muscle & Nerve|March 28, 2017
Start high, then go low: An effective strategy in the treatment of myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Journal of Clinical Neuromuscular Disease|May 30, 2014
Treatment-refractory myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Neurologic Clinics|April 16, 2018
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and EpidemiologyMichael K Hehir, Nicholas J Silvestri
Neurology|January 22, 2016
Comment: Salbutamol--A means to an endplateGil I Wolfe, Nicholas J Silvestri
Seminars in Neurology|November 3, 2012
Myasthenia gravisNicholas J Silvestri, Gil I Wolfe
Muscle & Nerve|April 30, 2013
Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia)Nicholas J Silvestri, Gil I Wolfe
Pageof 5